EasyLyo provides stronger packaging that is more resistant and suitable to extreme conditions encountered during the lyophilization process. EasyLyo is a range of Type I glass vials combining the strength of molded glass with superior cosmetic quality and weight reduction.
- Same composition as regular Type I
- Same production plant
- No regulatory change in Type I molded glass
Controlled internal diameter
- Minimize stopper pop-up and improve
- Container Closure Integrity (CCI)
30% less mass than standard molded vials
- Improved energy cost and footprint
Optimized heel radius
- High mechanical resistance
ISO 20mm
- As per standard neck size for injectable
Uniform wall thickness
- High mechanical resistance and better inspectability
Same external dimension as tubular vials for 20ml and 25ml
- Minor changes on the filling line and same shelf
configuration on the freeze-dryer
Flatter base & base mold marks removed
- To enhance and maximize heat transfer
A innovative design
Optimized base design to enhance heat transfer
The vial was especially designed to improve heat transfer through the base of vial during freeze-drying process. The new design includes a flat bottom without stippling, and an optimized radius
Better inspectability
EasyLyo vials show a noticeable improvement of cosmetic quality, compared to regular molded vials, thanks to a much more uniform thickness by SGD Pharma specific technology
High mechanical resistance
EasyLyo vials have a uniform wall thickness that offer physical resistance. Compared to tubular vials, EasyLyo vials are 3 to 4 times more resistant in terms of vertical load (stoppering stage) and 2 times more resistant in terms of radial load (loading/unloading stage)
Learn more about EasyLyo
Did you know that ?
EasyLyo vials are part of the Sterinity platform, which means they are available in a sterile, depyrogenated and Ready-To-Use format (RTU).
Choose your product
EasyLyo
SGD Pharma has designed EasyLyo, a whole range of injectable molded glass vials with good chemical durability, greater physical strength and improved cosmetic quality for liquid and lyophilized drugs.
SGD Pharma’s segmented Type I portfolio : two options to reflect your financial, service, and quality needs.
